Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 226,577 | 133,814 | 225,250 | 119,497 | 324,505 |
| Cost of Goods | 3,829 | 1,071 | 4,164 | 2,151 | 3,062 |
| Gross Profit | 222,748 | 132,743 | 221,086 | 117,346 | 321,443 |
| Operating Expenses | 334,398 | 281,470 | 287,341 | 267,010 | 327,627 |
| Operating Income | -110,821 | -148,656 | -66,091 | -149,513 | -6,122 |
| Interest Expense | 22,861 | 22,694 | 22,786 | 22,110 | 22,406 |
| Other Income | 26,644 | 27,249 | 22,676 | 28,895 | 25,762 |
| Pre-tax Income | -107,038 | -144,101 | -66,201 | -142,728 | -2,766 |
| Income Tax | -2,689 | -3,621 | 64 | 75 | 6,497 |
| Net Income Continuous | -104,349 | -140,480 | -66,265 | -142,803 | -9,263 |
| Net Income | $-104,349 | $-140,480 | $-66,265 | $-142,803 | $-9,263 |
| EPS Basic Total Ops | -0.66 | -0.95 | -0.45 | -0.98 | -0.06 |
| EPS Basic Continuous Ops | -0.66 | -0.95 | -0.45 | -0.98 | -0.06 |
| EPS Diluted Total Ops | -0.66 | -0.95 | -0.45 | -0.98 | -0.06 |
| EPS Diluted Continuous Ops | -0.66 | -0.95 | -0.45 | -0.98 | -0.06 |
| EPS Diluted Before Non-Recurring Items | -0.66 | -0.95 | -0.45 | N/A | N/A |
| EBITDA(a) | $-113,330 | $-150,625 | $-68,727 | $-151,452 | $-7,335 |